Research highlights urgent need for specialist ketamine services as harms among young people rise

16 November, 2026

A group of people sit at a long table. It is a group therapy session. They are talking and smiling.

A study led by researchers at the University of South Wales (USW) has highlighted the growing impact of ketamine dependence on young people and called for improved treatment services availability and guidance to support those affected.

The research, conducted in partnership with the drug and alcohol treatment service Kaleidoscope, evaluated the specialist ketamine detox and rehabilitation programme at Birchwood House, a residential treatment centre in Wirral. Researchers interviewed service users, gathered views from healthcare professionals, and analysed anonymised case records to better understand the experiences and needs of people seeking help for ketamine dependence.

The study comes amid growing concern about ketamine use in the UK. National figures show the number of people entering treatment for ketamine-related problems has increased dramatically over the past decade, while reports of ketamine-related deaths and severe health complications are also rising. Recent media coverage has highlighted increasing numbers of young people presenting to specialist services with serious bladder damage linked to prolonged ketamine use.

Led by Dr Darren Quelch, Senior Research Fellow at USW, the study found that many participants began using ketamine in their mid-teens, often with little awareness of the serious physical and psychological harms associated with long-term use.

Participants described ketamine as cheap, readily available, and initially perceived as less harmful than other illicit substances. Researchers found that occasional use could quickly escalate into dependent patterns of use associated with severe pain, bladder damage, gastrointestinal problems, mental health difficulties, and significant disruption to daily life and wellbeing.

The report also highlighted a need to raise awareness of ketamine-related harms and effective treatment options among healthcare professionals. Many participants reported being misdiagnosed or told simply to stop using the drug without receiving specialist support.

Dr Darren Quelch said: “What was striking from this research was how quickly ketamine use could progress from occasional recreational use to severe dependence accompanied by complex health problems. Many of the people we spoke to were experiencing debilitating pain, bladder damage, and significant impact on their mental wellbeing before they were able to access specialist support.

“Service users and healthcare professionals were united in recognising that ketamine use disorder presents unique challenges that differ from other substance use disorders. There is an urgent need to improve awareness of ketamine-related harms and develop evidence-based treatment services.”

The study found strong support for the care provided at Birchwood House, with service users praising the specialist knowledge of staff, the structured treatment environment and the peer support available during detox and rehabilitation. However, researchers identified several system-wide challenges, including limited access to specialist rehabilitation services, inconsistent referral processes, and a lack of national clinical guidance for managing ketamine dependence.

Among the report’s recommendations are the development of national guidelines for ketamine detox and rehabilitation, increased education and prevention work in schools and universities, greater awareness training for healthcare professionals, and further research into pain management, which was identified as a major factor contributing to relapse.

The researchers also highlight the importance of tailoring services to the specific needs of ketamine users, who are often younger than those accessing treatment for other substances or alcohol, and, as a result, may face distinct health, social, and psychological challenges.

Jo Moore runs the Birchwood rehabilitation facility for Kaleidoscope. She said: “Five years ago we had just one referral for inpatient detox from ketamine.

"The challenge for both the third sector and the NHS is to adapt around the needs of clients, and involving people with lived experience in research has made a huge difference. We’ll continue to adapt to meet demand, but it's important that investment keeps pace with changing patterns of drug use."

The project was supported through an Accelerated Knowledge Transfer Partnership grant from UK Research and Innovation (UKRI) in collaboration with Kaleidoscope.

 

Image courtesy of Empathy Lens Collection.